Filarial Infection or Antigen Administration Improves Glucose Tolerance in Diet-Induced Obese Mice. 2016

Afiat Berbudi, and Jayagopi Surendar, and Jesuthas Ajendra, and Fabian Gondorf, and David Schmidt, and Anna-Lena Neumann, and Ajeng P F Wardani, and Laura E Layland, and Linda S Hoffmann, and Alexander Pfeifer, and Achim Hoerauf, and Marc P Hübner
Institute for Medical Microbiology, Immunology and Parasitology, University Hospital of Bonn, Bonn, Germany.

Helminths induce type 2 immune responses and establish an anti-inflammatory milieu in their hosts. This immunomodulation was previously shown to improve diet-induced insulin resistance which is linked to chronic inflammation. In the current study, we demonstrate that infection with the filarial nematode Litomosoides sigmodontis increased the eosinophil number and alternatively activated macrophage abundance within epididymal adipose tissue (EAT) and improved glucose tolerance in diet-induced obese mice in an eosinophil-dependent manner. L. sigmodontis antigen (LsAg) administration neither altered the body weight of animals nor adipose tissue mass or adipocyte size, but it triggered type 2 immune responses, eosinophils, alternatively activated macrophages, and type 2 innate lymphoid cells in EAT. Improvement in glucose tolerance by LsAg treatment remained even in the absence of Foxp3+ regulatory T cells. Furthermore, PCR array results revealed that LsAg treatment reduced inflammatory immune responses and increased the expression of genes related to insulin signaling (Glut4, Pde3b, Pik3r1, and Hk2) and fatty acid uptake (Fabp4 and Lpl). Our investigation demonstrates that L. sigmodontis infection and LsAg administration reduce diet-induced EAT inflammation and improve glucose tolerance. Helminth-derived products may, therefore, offer new options to improve insulin sensitivity, while loss of helminth infections in developing and developed countries may contribute to the recent increase in the prevalence of type 2 diabetes.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004804 Eosinophils Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin. Eosinophil

Related Publications

Afiat Berbudi, and Jayagopi Surendar, and Jesuthas Ajendra, and Fabian Gondorf, and David Schmidt, and Anna-Lena Neumann, and Ajeng P F Wardani, and Laura E Layland, and Linda S Hoffmann, and Alexander Pfeifer, and Achim Hoerauf, and Marc P Hübner
May 2013, Molecular and cellular endocrinology,
Afiat Berbudi, and Jayagopi Surendar, and Jesuthas Ajendra, and Fabian Gondorf, and David Schmidt, and Anna-Lena Neumann, and Ajeng P F Wardani, and Laura E Layland, and Linda S Hoffmann, and Alexander Pfeifer, and Achim Hoerauf, and Marc P Hübner
October 2020, Nutrients,
Afiat Berbudi, and Jayagopi Surendar, and Jesuthas Ajendra, and Fabian Gondorf, and David Schmidt, and Anna-Lena Neumann, and Ajeng P F Wardani, and Laura E Layland, and Linda S Hoffmann, and Alexander Pfeifer, and Achim Hoerauf, and Marc P Hübner
July 2008, American journal of physiology. Endocrinology and metabolism,
Afiat Berbudi, and Jayagopi Surendar, and Jesuthas Ajendra, and Fabian Gondorf, and David Schmidt, and Anna-Lena Neumann, and Ajeng P F Wardani, and Laura E Layland, and Linda S Hoffmann, and Alexander Pfeifer, and Achim Hoerauf, and Marc P Hübner
September 2015, Amino acids,
Afiat Berbudi, and Jayagopi Surendar, and Jesuthas Ajendra, and Fabian Gondorf, and David Schmidt, and Anna-Lena Neumann, and Ajeng P F Wardani, and Laura E Layland, and Linda S Hoffmann, and Alexander Pfeifer, and Achim Hoerauf, and Marc P Hübner
November 2015, Endocrinology,
Afiat Berbudi, and Jayagopi Surendar, and Jesuthas Ajendra, and Fabian Gondorf, and David Schmidt, and Anna-Lena Neumann, and Ajeng P F Wardani, and Laura E Layland, and Linda S Hoffmann, and Alexander Pfeifer, and Achim Hoerauf, and Marc P Hübner
January 2014, PloS one,
Afiat Berbudi, and Jayagopi Surendar, and Jesuthas Ajendra, and Fabian Gondorf, and David Schmidt, and Anna-Lena Neumann, and Ajeng P F Wardani, and Laura E Layland, and Linda S Hoffmann, and Alexander Pfeifer, and Achim Hoerauf, and Marc P Hübner
November 2023, Diabetes, obesity & metabolism,
Afiat Berbudi, and Jayagopi Surendar, and Jesuthas Ajendra, and Fabian Gondorf, and David Schmidt, and Anna-Lena Neumann, and Ajeng P F Wardani, and Laura E Layland, and Linda S Hoffmann, and Alexander Pfeifer, and Achim Hoerauf, and Marc P Hübner
September 2018, Biochemical and biophysical research communications,
Afiat Berbudi, and Jayagopi Surendar, and Jesuthas Ajendra, and Fabian Gondorf, and David Schmidt, and Anna-Lena Neumann, and Ajeng P F Wardani, and Laura E Layland, and Linda S Hoffmann, and Alexander Pfeifer, and Achim Hoerauf, and Marc P Hübner
February 2013, Experimental physiology,
Afiat Berbudi, and Jayagopi Surendar, and Jesuthas Ajendra, and Fabian Gondorf, and David Schmidt, and Anna-Lena Neumann, and Ajeng P F Wardani, and Laura E Layland, and Linda S Hoffmann, and Alexander Pfeifer, and Achim Hoerauf, and Marc P Hübner
August 2006, Life sciences,
Copied contents to your clipboard!